Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06375512
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-04-17
Brief Title:
A Study to Describe the Safety Reactogenicity and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine IN001 in Healthy Participants
Sponsor:
Shenzhen Shenxin Biotechnology Co Ltd
Organization:
Shenzhen Shenxin Biotechnology Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Herpes Zoster |
Keywords:
| Name | View |
|---|---|
| Skin Diseases | View |
| IN001 | View |
| mRNA Vaccine | View |
| Vaccine | View |
| Varicella-zoster Virus | View |
| VZV | View |
| Viral Diseases | View |
| Shingles | View |
| Messenger RNA | View |
| Herpes Zoster HZ | View |
| Skin Diseases Infectious | View |
| Safety | View |
| Reactogenicity | View |
| Immunogenicity | View |
| Innorna | View |
| Shenxin | View |
| Herpesviridae Infections | View |
| DNA Virus Infections | View |
| Infections | View |
| Varicella Zoster Virus Infection | View |
| Skin Diseases Viral | View |